BSE Live
Dec 09, 16:01Prev. Close
384.05
Open Price
384.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 09, 15:59Prev. Close
383.80
Open Price
383.00
Bid Price (Qty.)
383.65 (188)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Biocon (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 6,144.80 | 5,381.10 | 3,984.40 | 3,876.30 | 3,291.60 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 6.30 | 30.50 | 33.60 | |
| Revenue From Operations [Net] | 6,144.80 | 5,381.10 | 3,978.10 | 3,845.80 | 3,258.00 | |
| Total Operating Revenues | 6,300.50 | 5,514.40 | 4,123.40 | 3,891.10 | 3,347.40 | |
| Other Income | 161.40 | 144.40 | 206.20 | 157.10 | 79.20 | |
| Total Revenue | 6,461.90 | 5,658.80 | 4,329.60 | 4,048.20 | 3,426.60 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 2,104.90 | 2,029.90 | 1,445.00 | 1,322.40 | 1,254.90 | |
| Purchase Of Stock-In Trade | 85.40 | 76.40 | 232.80 | 193.20 | 76.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -200.80 | -209.70 | -41.70 | -69.00 | -40.50 | |
| Employee Benefit Expenses | 1,458.80 | 1,165.30 | 931.10 | 747.00 | 610.10 | |
| Finance Costs | 64.90 | 70.90 | 61.50 | 26.00 | 29.30 | |
| Depreciation And Amortisation Expenses | 552.20 | 447.80 | 385.10 | 277.20 | 248.70 | |
| Other Expenses | 1,249.10 | 1,328.70 | 901.80 | 846.30 | 811.10 | |
| Total Expenses | 5,314.50 | 4,639.40 | 3,740.90 | 3,214.80 | 2,857.60 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,147.40 | 1,019.40 | 588.70 | 833.40 | 569.00 | |
| Exceptional Items | 67.50 | 194.60 | 0.00 | 0.00 | 160.60 | |
| Profit/Loss Before Tax | 1,214.90 | 1,214.00 | 588.70 | 833.40 | 729.60 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 271.30 | 203.80 | 152.20 | 208.20 | 181.30 | |
| Less: MAT Credit Entitlement | 37.40 | 13.80 | 25.90 | 36.90 | 16.60 | |
| Deferred Tax | 81.20 | 22.30 | 30.60 | -9.70 | -22.50 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 315.10 | 212.30 | 156.90 | 161.60 | 142.20 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 899.80 | 1,001.70 | 431.80 | 671.80 | 587.40 | |
| Profit/Loss From Continuing Operations | 899.80 | 1,001.70 | 431.80 | 671.80 | 587.40 | |
| Profit/Loss For The Period | 870.90 | 1,001.70 | 431.80 | 671.80 | 587.40 | |
| Minority Interest | -122.70 | -97.30 | -80.70 | -76.00 | -58.70 | |
| Consolidated Profit/Loss After MI And Associates | 748.20 | 905.30 | 372.40 | 612.10 | 550.40 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 6.00 | 8.00 | 6.00 | 10.00 | 28.00 | |
| Diluted EPS (Rs.) | 6.00 | 8.00 | 6.00 | 10.00 | 28.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 63.00 | 72.20 | 72.50 | 0.00 | 114.80 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
09.12.2025
08.12.2025
20.11.2025
Biocon falls 5% after Citi double downgrades stock to 'Sell'; Check latest target price
19.11.2025
Biocon Consolidated September 2025 Net Sales at Rs 4,295.50 crore, up 19.64% Y-o-Y